Alpha-GPC Market Size & Growth Analysis to 2030

The global alpha GPC market size was valued at around USD 1 billion in 2020 and accounted to grow at a significant CAGR of ~ 10.5% during the forecast period 2021 to 2027. The alpha GPC is also known as choline alfoscerate, which is used to treat Alzheimer’s illness and other dementias. The increasing incidence of Alzheimer’s patients across the globe is a primary factor to drive the market growth. It is estimated that 5.8 people are living with Alzheimer’s dementia in the US with the age of 65 years and older. Furthermore, increasing demand for brain health supplements is another factor to fuel the alpha GPC demand.

Market Snapshot:

Market Drivers:

Increasing Demand for Cognitive Health Supplements: There is a growing interest in cognitive health and brain function optimization among individuals of all age groups. Alpha-GPC is known for its potential cognitive benefits, such as improving memory, focus, and mental clarity. The increasing demand for cognitive health supplements and nootropics drives the growth of the alpha-GPC market.

Aging Population and Cognitive Decline Concerns: With the aging population, there is a rising concern about age-related cognitive decline and neurodegenerative disorders such as Alzheimer’s disease. Alpha-GPC has been studied for its potential role in improving cognitive function and mitigating cognitive decline. As the population ages and the prevalence of age-related cognitive disorders increases, the demand for alpha-GPC as a potential preventive or therapeutic supplement grows.

Increasing Awareness and Adoption in Sports Nutrition: Alpha-GPC has gained popularity in the sports and fitness industry due to its potential to enhance physical performance and stimulate growth hormone secretion. Athletes and fitness enthusiasts are increasingly using alpha-GPC to improve muscle strength, power, and endurance. The growing awareness of the benefits of alpha-GPC in sports nutrition drives its market growth.

Research and Clinical Studies: Ongoing research and clinical studies on alpha-GPC have provided evidence of its potential benefits, safety, and efficacy. Positive findings from these studies contribute to the growing acceptance and demand for alpha-GPC among consumers, healthcare professionals, and the nutraceutical industry.

Growing Preference for Natural and Nutritional Supplements: There is a shifting consumer preference towards natural and nutritional supplements over synthetic alternatives. Alpha-GPC, derived from natural sources such as soy or other plant-based materials, aligns with this preference. The demand for natural and plant-based supplements drives the growth of the alpha-GPC market.

Increasing Health and Wellness Consciousness: People are increasingly focusing on maintaining their overall health and wellness. Alpha-GPC is considered a part of the broader category of nootropics and supplements that support mental and cognitive well-being. The growing health and wellness consciousness among consumers fuels the demand for alpha-GPC as a nutritional supplement.

Favorable Regulatory Environment: Regulatory bodies in various countries have established regulations and guidelines for the use of dietary supplements. The existence of favorable regulations and safety standards encourages the production, marketing, and consumption of alpha-GPC as a dietary supplement. A supportive regulatory environment contributes to the growth of the alpha-GPC market.

Market Insights:

The global alpha GPC market is segmented into application and region. On the basis of application, the market is classified into Alzheimer’s disease, cerebral ischemia, and others. The Alzheimer’s disease segment held the largest market share in 2020 and projected to grow at the same trend over the forecast period. The Alzheimer’s disease segment is accounted to hold a major market share of over 45% in terms of revenue. The segment growth is attributed to the rising prevalence of Alzheimer’s disease and other dementias across the globe in age of 65 years and older.

For more information about the study, request a report sample

The alpha GPC comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2020 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Global alpha GPC market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

The alpha GPC market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

• 2018-19 – Historical Year
• 2020 – Base Year
• 2021-2027 – Forecast Period

Market Segmentation:

By Application:

• Alzheimer’s Disease
• Cerebral Ischemia
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage:

Geographically, the Alpha GPC market report comprises dedicated sections centering on the regional market revenue and trends. The Alpha GPC market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The Alpha GPC market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Alpha GPC market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Competition Assessment:

Key players operating in the global Alpha GPC market are Avanti Lipids Polar, Inc., ITALFARMACO S.p.A., Enzychem Lifesciences Corporation, and Shanghai Yiyao Biological Technology Co., Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Avanti Lipids Polar, Inc.
• ITALFARMACO S.p.A.
• Enzychem Lifesciences Corporation
• Shanghai Yiyao Biological Technology Co., Ltd
• BOC Sciences
• Maxsun Industries, Inc.
• Chlorine Glycerophosphate
• MDM SpA
• BBFarma Srl

Key Questions Answered by Alpha GPC Market Report:

• Global Alpha GPC market forecasts from 2021-2027
• Regional Alpha GPC market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
• Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
• Alpha GPC submarket forecasts from 2021-2027 covering the market by application, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to Alpha GPC market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level Alpha GPC markets from 2021-2027
• Competitive Landscape and market positioning of top 10 players operating in the Alpha GPC market